Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.180
+0.060 (2.83%)
At close: Jan 7, 2026, 4:00 PM EST
2.190
+0.010 (0.44%)
After-hours: Jan 7, 2026, 7:58 PM EST
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $105.31 million as of January 7, 2026. Its market cap has decreased by -9.17% in one year.
Market Cap
105.31M
Enterprise Value
-768.79K
1-Year Change
-9.17%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $105.31M, a decrease of -50.46%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 102.41M | 7.07% |
| Dec 31, 2025 | 95.65M | -15.76% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.51B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |